Posted on by

CJC-1295 Clinical Research: Human Trials, DAC Technology, and Safety Findings

3D visualization of a modified peptide molecule conjugating to a serum albumin protein structure.

CJC-1295 is an investigational growth hormone-releasing hormone analogue engineered with Drug Affinity Complex technology for extended half-life. While ear

Read more CJC-1295 Clinical Research: Human Trials, DAC Technology, and Safety Findings

Posted on by

5-Amino-1MQ Mechanism: NNMT Inhibition, NAD+ Dynamics, and Cellular Metabolism

3D visualization of the NNMT enzyme catalytic site interacting with a small-molecule inhibitor.

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT). By preventing nicotinamide degradation and conserving S-adenosylmethi

Read more 5-Amino-1MQ Mechanism: NNMT Inhibition, NAD+ Dynamics, and Cellular Metabolism

Posted on by

The Science of MOTS-c: Mitochondrial Signaling, Metabolic Homeostasis, and Exercise Physiology

3D visualization of mitochondrial-derived peptide MOTS-c signaling between the mitochondrion and cell nucleus.

MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA. It acts as a retrograde signaling molecule that activates AMPK, regulates metabolic hom

Read more The Science of MOTS-c: Mitochondrial Signaling, Metabolic Homeostasis, and Exercise Physiology

Posted on by

Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show

3D visualization of dual incretin peptide interacting with transmembrane cell receptors.

A comprehensive review of the clinical evidence for tirzepatide, examining glycemic and weight loss outcomes across the landmark SURPASS and SURMOUNT phase

Read more Tirzepatide Clinical Evidence: What the SURPASS and SURMOUNT Trials Show